See research from the lab on Google Scholar.

Everyone is very welcome to be in touch to request free full-text copies of any of our publications. No payments are required to journals and such payments do not support our research. Please contact us directly if you are unable to locate copies of our work online and we will be happy to send you a copy, free of charge.

Highlights

TDP-43 pathology: from noxious assembly to therapeutic removal

Keating SS, San Gil R, Swanson MEV, Scotter EL, Walker AK

Progress in Neurobiology, 211: 102229 (2022)

Accepted article (available to all) here

Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis

Wright AL, Della Gatta PA, Le S, Berning BA, Mehta P, Jacobs KR, Gul H, San Gil R, Hedl TJ, Riddell WR, Watson O, Keating SS, Venturato J, Chung RS, Atkin JD, Lee A, Shi B, Blizzard CA, Morsch M, Walker AK

European Journal of Neuroscience, 54: 6237 (2021)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD

Hedl TJ, San Gil R, Cheng F, Rayner SL, Davidson JM, De Luca A, Villalva MD, Ecroyd H, Walker AK*, Lee A*

Frontiers in Neuroscience, 13: 548 (2019) (*co-corresponding)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD

Berning BA, Walker AK

Frontiers in Neuroscience, 13: 335 (2019)

Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43

Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, Tripathy K, Kwong LK, Trojanowski JQ, Lee VM-Y

Acta Neuropathologica, 130: 643 (2015)